Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arrowhead Pharmaceuticals

13.03
-0.2200-1.66%
Post-market: 13.030.00000.00%19:47 EDT
Volume:1.25M
Turnover:16.37M
Market Cap:1.79B
PE:-2.53
High:13.98
Open:13.26
Low:12.89
Close:13.25
Loading ...
Sep 14, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 10, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 27, 2021

Major Issues Report

ARROWHEAD PHARMACEUTICALS, INC.
Jun 25, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jun 22, 2021

Major Issues Report

8-K - Current report
Jun 16, 2021

Major Issues Report

8-K - Current report
May 18, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 04, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2021

Major Issues Report

8-K - Current report
Mar 24, 2021

Major Issues Report

8-K - Current report
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 04, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 04, 2021

Major Issues Report

8-K - Current report
Jan 27, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 23, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 23, 2020

Major Issues Report

8-K - Current report
Oct 09, 2020

Major Issues Report

8-K - Current report
Sep 08, 2020

Major Issues Report

8-K - Current report
Aug 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]